Replies to post #744752 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

dstock is a speculative force of nature. I have no idea what to make of his observations on BP cancer vaccine facility building.

As far as Merck, many institutions have been complaining about unreliable BCG TICE supply.

Here is one that went elsewhere. https://www.fiercepharma.com/manufacturing/rival-merck-monopolizes-bcg-supply-immuntybio-taps-serum-institute-new-combos

The New Jersey Big Pharma [Merck] allocates its limited supply to distributors and wholesalers based on historical purchasing, and it doesn’t directly determine the supply to individual healthcare providers.

[SkyLimit2022]

zero82,

“it appears” “seems” ?? 😶

You can post your opinions about what you think Merck might do or not do, but facts might be more interesting than your opinions on the topic of BP companies such as Merck…

Currently, Merck’s pembrolizumab is being studied in combo with two of the novel dendritic cell technologies owned by NWBO. The studies are being conducted by UCLA and Roswell Park, interim efficacy data are beginning to emerge, and the trials are supported by continuing peer-reviewed grants awarded by the U.S. NIH and the U.S. DoD.

We don’t have to draw any conclusions, but those are true and noteworthy facts on the topic of Merck.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175149927

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175085456

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175399357